You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 17, 2026

Claims for Patent: 4,786,910


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,786,910
Title: Single reflector multibeam antenna arrangement with a wide field of view
Abstract:The present invention relates to an antenna comprising a plurality of feeds, and either a single reflector or a single lens wherein the reflector or lens includes a predetermined curved major surface that produces a maximum field of view in a first one of two principal planes of the antenna. The major curved surface is designed to produce a first and a second \"stigmatic\" focal point, which are spaced apart by a predetermined amount on either side of an axis normal to the center of the reflector or lens in the first principal plane, such that the coefficient of astigmatism is at a maximum predetermined tolerable amount at the center and at the opposite edges of the maximum field of view to produce a peanut-shaped area where the coefficient of astigmatism is within tolerable limits. For the lens design, the plurality of feeds can be disposed within the peanut-shaped area, while for the reflector design the feeds should preferably be disposed within the peanut-shaped area where no antenna aperture blockage occurs.
Inventor(s): Dragone; Corrado (Little Silver, NJ)
Assignee: American Telephone and Telegraph Company, AT&T Bell Laboratories (Murray Hill, NJ)
Application Number:07/117,109
Patent Claims:1. An antenna for producing a maximum desired field of view in a first one of two orthogonal principal planes, the antenna comprising:

a device including both (A) a major surface which is curved in each of the two orthogonal principal planes to produce a first and a second focal point on a focal surface of the device line the first of the two principal planes, and (B) a focal length diameter (f/D) ratio which is of a magnitude such that the only significant aberration is astigmatism, the first and second focal points being spaced apart on either side of the axis normal to the center of the curved major surface by a predetermined amount such that (1) a coefficient of astigmatism is essentially at a maximum tolerable amount at both a central point and at opposite edges of the field of view of the device in the first principal plane; and (2) a peanut-shaped area is produced (a) wherein the coefficient of astigmatism is equal to or less than the maximum tolerable coefficient of astigmatism, and (b) which is widest along the first principal plane; and

a plurality of feeds disposed both on the focal surface of the device and in the peanut-shaped area, each feed including a longitudinal axis which is directed at the device for propagating, in any one of two directions along the longitudinal axis, beams which include (1) a spherical wavefront when propagating between a feed and the device, and (2) a substantially planar wavefront when propagating between the device and a remote location.

2. An antenna according to claim 1 wherein the device is a reflector.

3. An antenna according to claim 2 wherein the plurality of feeds are disposed to avoid aperture blockage of any portion of a substantially planar wavefront.

4. An antenna according to claim 1 wherein the device is a lens.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.